Margaret Hahn

Margaret Hahn is an Affiliate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. She maintains a dual affiliation with the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, as indicated by her institutional email address.

Her research program focuses on the critical intersection between psychiatric treatment and physical health outcomes, with particular emphasis on metabolic complications associated with antipsychotic medications. Dr. Hahn investigates how these medications affect glucose homeostasis, contribute to weight gain, and increase risk for metabolic disorders among individuals with serious mental illness.

Her scholarly work spans multiple domains including clinical trials, systematic reviews, translational neuroscience using animal models, and innovative stem cell approaches. She has made significant contributions to international guideline development through projects like INTEGRATE for schizophrenia treatment and the Lancet Psychiatry Physical Health Commission.

• Extensive publication record in high-impact journals including JAMA Psychiatry, Nature Metabolism, and The Lancet Psychiatry
• Research examining both pharmacological interventions (like GLP-2 and metformin) and holistic approaches to managing physical health side effects
• Active collaborator in international research networks addressing psychiatric medication safety

Her work has received notable attention across academic and public spheres, with multiple publications featured in news outlets and widely discussed on social media platforms, reflecting the clinical importance of her research on improving physical health outcomes in psychiatric care.